While most psychiatric patients are familiar with psychotherapy and medications, they may not be as familiar with TMS (transcranial magnetic stimulation) Psychiatry. TMS is a noninvasive procedure that uses magnetic fields to stimulate the brain to improve symptoms of depression and OCD. Clinical trials are also underway for additional brain disorders. TMS is typically used when other treatments have proven to be ineffective for mental health patients.
Providing patients with another option, BrainsWay – utilizing an innovative TMS technology – offers a non-invasive, efficacious, and well-tolerated treatment that activates deep brain structures using directed electromagnetic fields which generate excitation or inhibition of neurons inside the brain. BrainsWay represents the next-generation of TMS Psychiatry treatment for depression and OCD, achieving outcomes not thought possible with traditional medical solutions.
The Advantages of BrainsWay’s TMS Psychiatry
The advantages of TMS psychiatry – specifically BrainsWay’s FDA-cleared therapies for MDD and OCD – are the following:
Provide Patients with More Options
BrainsWay Deep TMS™ is a powerful treatment method that should be added as a viable alternative to doctors’ and patients’ existing list of potential treatment options. Deep TMS can be effective even where other treatment options have failed.
Safe & Effective
BrainsWay therapy has been demonstrated to be effective for many patients, has a favorable safety profile and is generally well-tolerated for the treatment of patients with MDD and OCD. Side effects are non-systemic, with the most common side effect being minor headaches which often dissipate over the course of the treatment.
Non-Invasive Technology
BrainsWay’s treatment non-invasively stimulates the brain using brief magnetic fields. It does not require hospitalization or anesthesia.
Short, Clinically Proven Treatments
BrainsWay treatment sessions last around just 20 minutes, allowing for minimal disruption in the patient’s routine.